Sionna Therapeutics, Inc. (SION)
NASDAQ: SION · Real-Time Price · USD
39.41
-0.18 (-0.45%)
Apr 29, 2026, 11:31 AM EDT - Market open
Sionna Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 1,779 | 1,836 | - | - | - |
| Enterprise Value | 1,453 | 1,520 | - | - | - |
| Last Close Price | 39.59 | 41.14 | - | - | - |
| PB Ratio | 5.77 | 5.98 | - | - | - |
| P/TBV Ratio | 5.72 | 5.98 | - | - | - |
| Debt / Equity Ratio | 0.03 | 0.03 | 0.06 | 0.31 | - |
| Net Debt / Equity Ratio | -0.98 | -0.98 | -0.95 | -0.82 | -1.04 |
| Net Debt / EBITDA Ratio | 3.42 | 3.42 | 2.27 | 0.56 | 2.00 |
| Net Debt / FCF Ratio | 4.52 | 4.52 | 3.00 | 0.63 | 2.18 |
| Quick Ratio | 20.14 | 20.14 | 14.16 | 4.79 | 10.01 |
| Current Ratio | 20.61 | 20.61 | 14.49 | 4.88 | 10.16 |
| Return on Equity (ROE) | -31.79% | -31.79% | -61.44% | -83.45% | - |
| Return on Assets (ROA) | -21.74% | -21.74% | -37.10% | -45.16% | - |
| Return on Capital Employed (ROCE) | -28.30% | -28.30% | -40.20% | -114.60% | -52.30% |
| Earnings Yield | -4.29% | -4.10% | - | - | - |
| FCF Yield | -3.80% | -3.63% | - | - | - |
| Buyback Yield / Dilution | -935.60% | -935.60% | -31.56% | -13.80% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.